PharmaBiome Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • (Upcoming)
  • Investors
  • 6

PharmaBiome General Information

Description

Developer of a medical technology platform designed to formulate fecal microbiota transplant products. The company's platform makes microbiota therapy the new standard for the treatment of intestinal diseases and treats intestinal infections without using fecal transplants, enabling patients to recover intestinal infections such as difficile infection.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Surgical Devices
Primary Office
  • Schmelzbergstrasse 7
  • 8092 Zurich
  • Switzerland
+41 044 000 00 00

PharmaBiome Timeline

2018201920202021
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaBiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) Upcoming Pre-Clinical Trials
5. Angel (individual) 08-Jul-2020 00.000 00.000 Completed Pre-Clinical Trials
4. Accelerator/Incubator 16-Jan-2020 00000 00000 Completed Pre-Clinical Trials
3. Accelerator/Incubator 03-Dec-2019 00000 Completed Startup
2. Grant 31-Jul-2018 $83.5K $128K Completed Startup
1. Accelerator/Incubator 14-Jun-2016 $128K $128K 00000 Completed Startup
To view PharmaBiome’s complete valuation and funding history, request access »

PharmaBiome Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 000
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 00
To view PharmaBiome’s complete cap table history, request access »

PharmaBiome Executive Team (3)

Name Title Board Seat Contact Info
Tomas de Wouters Ph.D Co-Founder, Board Member & Chief Executive Officer
Florian Rosenthal Ph.D Chief Operating Officer
Manuel Banz Co-Founder
To view PharmaBiome’s complete executive team members history, request access »

PharmaBiome Board Members (6)

Name Representing Role Since
Alexey Borichev PharmaBiome Board Member 000 0000
Christophe Lacroix Ph.D PharmaBiome Board Member 000 0000
Gerhard Rogler Ph.D PharmaBiome Board Member 000 0000
Patrik Forrer Ph.D Self Board Member 000 0000
Thomas Meier Ph.D Self Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »

PharmaBiome Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Patrik Forrer Angel (individual) 000 0000 000000 0
Thomas Meier Angel (individual) 000 0000 000000 0
BaseLaunch Healthcare Accelerator Accelerator/Incubator 000 0000 000000 0
EIT Health Accelerator/Incubator 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »